Matches in Nanopublications for { ?s ?p ?o <http://purl.org/np/RAhN3pQJksh_0KrbKdsLTq8cuK0dnZRmdjPDlJhr9oxl0#assertion>. }
Showing items 1 to 10 of
10
with 100 items per page.
- association type Statement assertion.
- association label "relenza an influenza virus neuraminidase inhibitor nai is indicated for treatment of acute uncomplicated influenza type a and b infections 1 1 prophylaxis of influenza 1 2 important limitations of use not recommended for treatment or prophylaxis of influenza in 5 1 not proven effective for 1 3 1 3 not a substitute for annual influenza vaccination 1 3 consider available information on influenza drug susceptibility patterns and treatment effects when deciding whether to use relenza 1 3 relenza zanamivir inhalation powder is indicated for treatment of uncomplicated acute illness due to influenza a and b virus in adults and pediatric patients aged 7 years and older who have been symptomatic for no more than 2 days relenza is indicated for prophylaxis of influenza in adults and pediatric patients aged 5 years and older see warnings and precautions 5 1" assertion.
- association object DOID_8469 assertion.
- association predicate treats assertion.
- association subject drugbank:DB00558 assertion.
- association relation TreatmentIndication assertion.
- DOID_8469 category Disease assertion.
- drugbank:DB00558 category Drug assertion.
- association provided_by NeuroDKG assertion.
- association association_type ChemicalToDiseaseOrPhenotypicFeatureAssociation assertion.